Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.

Clinica Chimica Acta

Volumn 411, Issue 17-18, 2010, Pages 1354-1360

  Tomaschitz, Andreas ^a   Pilz, Stefan ^a   Ritz, Eberhard ^b   Grammer, Tanja ^c   Drechsler, Christiane ^d   Boehm, Bernhard O ^e   März, Winfried ^a,b,c  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c SYNLAB ACADEMY   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Renin angiotensin system; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ANGIOTENSIN II; CALCITRIOL; RENIN; 1,25-DIHYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGED; ANALYSIS OF COVARIANCE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENETIC ASSOCIATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TANDEM MASS SPECTROMETRY; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; BLOOD; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR;

AGED; ANALYSIS OF VARIANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; VITAMIN D;

EID: 77954144195     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.05.037     Document Type: Article

References (35)

1. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
2. Cavalier E., Delanaye P., Chapelle J.P., Souberbielle J.C. Vitamin D: current status and perspectives. Clin Chem Lab Med 2009, 47:120-127.
3. Zittermann A., Schleithoff S.S., Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005, 94:483-492.
4. Pilz S., März W., Wellnitz B., et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008, 93:3927-3935.
5. Pilz S., Tomaschitz A., Ritz E., Pieber T.R. Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 2009, 6:621-630.
6. Holick M.F. Vitamin D for health and in chronic kidney disease. Semin Dial 2005, 18:266-275.
7. Pilz S, Tomaschitz A, Drechsler C, Dekker JM, März W. Vitamin D deficiency and myocardial diseases. Mol Nutr Food Res in press.
8. Schmieder R.E., Hilgers K.F., Schlaich M.P., Schmidt B.M. Renin-angiotensin system and cardiovascular risk. Lancet 2007, 369:1208-1219.
9. Tomaschitz A., Pilz S., Ritz E., Meinitzer A., Boehm B.O., März W. Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Eur Heart J 2010 May, 31(10):1237-1247.
10. Tomaschitz A., Pilz S., Ritz E., Obermayer-Pietsch B., Pieber T.R. Aldosterone and arterial hypertension. Nat Rev Endocrinol 2010, 6:83-93.
11. Nguyen G., Delarue F., Burckle C., Bouzhir L., Giller T., Sraer J.D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002, 109:1417-1427.
12. Bouillon R., Carmeliet G., Verlinden L., et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008, 29:726-776.
13. Egan B.M., Basile J.N., Rehman S.U., et al. Plasma renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens 2009, 22:792-801.
14. Winkelmann B.R., Marz W., Boehm B.O., et al. Rationale and design of the LURIC study-a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2001, 2:S1-73.
15. Trenkel S., Seifarth C., Schobel H., Hahn E.G., Hensen J. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism. Exp Clin Endocrinol Diab 2002, 110:80-85.
16. Stevens L.A., Coresh J., Schmid C.H., et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008, 51:395-406.
17. Dobnig H., Pilz S., Scharnagl H., et al. Independent association of low serum 25-hydroxyvitamin d and 1, 25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008, 168:1340-1349.
18. Wagner C., Jensen B.L., Kramer B.K., Kurtz A. Control of the renal renin system by local factors. Kidney Int Suppl 1998, 67:S78-83.
19. Klein I.H., Ligtenberg G., Neumann J., Oey P.L., Koomans H.A., Blankestijn P.J. Sympathetic nerve activity is inappropriately increased in chronic renal disease. J Am Soc Nephrol 2003, 14:3239-3244.
20. Tomaschitz A., Pilz S. Aldosterone to renin ratio - a reliable screening tool for primary aldosteronism?. Horm Metab Res 2010 Jun, 42(6):382-391.
21. Tomaschitz A., März W., Pilz S., et al. Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range. J Am Coll Cardiol 2010, 55:2171-2180.
22. Kelly D.J., Wilkinson-Berka J.L., Allen T.J., Cooper M.E., Skinner S.L. A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR). Kidney Int 1998, 54:343-352.
23. Andress D. Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease. Drugs 2007, 67:1999-2012.
24. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., Cao L.P. 1, 25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002, 110:229-238.
25. Kong J., Li Y.C. Effect of ANG II type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice. Am J Physiol Regul Integr Comp Physiol 2003, 285:R255-261.
26. Pilz S, Tomaschitz A, Drechsler C, et al. Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J in press. http://doi:10.1093/eurheartj/ehq109.
27. Freundlich M., Quiroz Y., Zhang Z., et al. Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int 2008, 74:1394-1402.
28. Resnick L.M., Muller F.B., Laragh J.H. Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986, 105:649-654.
29. Park C.W., Oh Y.S., Shin Y.S., et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 1999, 33:73-81.
30. Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010; 55:1283-88.
31. Saadi H.F., Nicholls M.G., Frampton C.M., Benedict S., Yasin J. Serum 25-hydroxyvitamin D is not related to cardiac natriuretic peptide in nulliparous and lactating women. BMC Endocr Disord 2009, 9:4.
32. Sugden J.A., Davies J.I., Witham M.D., Morris A.D., Struthers A.D. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008, 25:320-325.
33. Jespersen B., Randlov A., Abrahamsen J., Fogh-Andersen N., Olsen N.V., Kanstrup I.L. Acute cardiovascular effect of 1, 25-dihydroxycholecalciferol in essential hypertension. Am J Hypertens 1998, 11:659-666.
34. Lind L., Wide L., Sorensen O.H., Ljunghall S. An association between mineral metabolism and the renin-aldosterone system in human hypertension. J Hum Hypertens 1989, 3:137-140.
35. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.